Market Research Logo

Bone Marrow Transplantation - Pipeline Review, H1 2016

Bone Marrow Transplantation - Pipeline Review, H1 2016

Summary

Global Markets Direct’s, ‘Bone Marrow Transplantation - Pipeline Review, H1 2016’, provides an overview of the Bone Marrow Transplantation pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Bone Marrow Transplantation, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Bone Marrow Transplantation and features dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the global therapeutic landscape of Bone Marrow Transplantation
  • The report reviews pipeline therapeutics for Bone Marrow Transplantation by companies and universities/research institutes based on information derived from company and industry-specific sources
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved Bone Marrow Transplantation therapeutics and enlists all their major and minor projects
  • The report assesses Bone Marrow Transplantation therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report summarizes all the dormant and discontinued pipeline projects
  • The report reviews latest news related to pipeline therapeutics for Bone Marrow Transplantation
Reasons to buy
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Bone Marrow Transplantation
  • Identify potential new clients or partners in the target demographic
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Bone Marrow Transplantation pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline


Introduction
Global Markets Direct Report Coverage
Bone Marrow Transplantation Overview
Therapeutics Development
Pipeline Products for Bone Marrow Transplantation - Overview
Pipeline Products for Bone Marrow Transplantation - Comparative Analysis
Bone Marrow Transplantation - Therapeutics under Development by Companies
Bone Marrow Transplantation - Therapeutics under Investigation by Universities/Institutes
Bone Marrow Transplantation - Pipeline Products Glance
Late Stage Products
Clinical Stage Products
Early Stage Products
Bone Marrow Transplantation - Products under Development by Companies
Bone Marrow Transplantation - Products under Investigation by Universities/Institutes
Bone Marrow Transplantation - Companies Involved in Therapeutics Development
Anchor Therapeutics, Inc.
Boryung Pharmaceutical Co., Ltd.
Cleveland BioLabs, Inc.
Compugen Ltd.
Mesoblast Limited
Pluristem Therapeutics Inc.
Taiga Biotechnologies, Inc.
Targazyme, Inc.
Bone Marrow Transplantation - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
(filgrastim + plerixafor) - Drug Profile
Product Description
Mechanism of Action
R&D Progress
ATI-2341 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
BR-05001 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
CBLB-612 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Cellular Immunotherapy for Bone Marrow Transplantation - Drug Profile
Product Description
Mechanism of Action
R&D Progress
CGEN-15001 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
MPC-CBE - Drug Profile
Product Description
Mechanism of Action
R&D Progress
PLXR-18 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Protein for Bone Marrow Transplantation - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit Perforin for Bone Marrow Transplantation - Drug Profile
Product Description
Mechanism of Action
R&D Progress
TZ-101 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Bone Marrow Transplantation - Recent Pipeline Updates
Bone Marrow Transplantation - Dormant Projects
Bone Marrow Transplantation - Discontinued Products
Bone Marrow Transplantation - Product Development Milestones
Featured News & Press Releases
Jan 12, 2016: Pluristem Receives U.S. FDA Clearance to Initiate Clinical Trial of PLX-R18 to Treat Insufficient Hematopoietic Recovery Following Bone Marrow Transplant
Nov 17, 2015: Pluristem to Present New Data on PLX-R18 at American Society of Hematology’s Annual Meeting
May 06, 2015: Pluristem Granted European Patent for Use of Cells to Help Treat Damaged Bone Marrow
Mar 24, 2015: Pluristem Announces Key Strategic Objectives for Development of PLX-R18 in Hematopoietic Indications
Mar 03, 2015: Pluristem and Hadassah Medical Center Announce Significant Data Showing PLX-R18 Cells Improve Bone Marrow Transplantation
Dec 04, 2014: Pluristem and Hadassah Medical Center Will Collaborate to Study Potential of PLX-RAD Cells to Improve Bone Marrow and Umbilical Cord Blood Transplant Outcomes
Nov 13, 2014: Cell Source's Megadose Drug Combination Receives Regulatory Approval in Italy to Commence Human Clinical Trials
Oct 27, 2014: Case Western Reserve University to Study Pluristem’s PLX-RAD Cells in Umbilical Cord Blood Transplants for the Treatment of Blood Cancers and Genetic Diseases
May 07, 2013: Pluristem Develops PLX-RAD Cells For Use In Hematology
Sep 05, 2012: Pluristem Therapeutics Announces Successfully Treatment Of Third Critically Ill Patient With PLX Cells Under Compassionate Use
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Number of Products under Development for Bone Marrow Transplantation, H1 2016
Number of Products under Development for Bone Marrow Transplantation - Comparative Analysis, H1 2016
Number of Products under Development by Companies, H1 2016
Number of Products under Investigation by Universities/Institutes, H1 2016
Comparative Analysis by Late Stage Development, H1 2016
Comparative Analysis by Clinical Stage Development, H1 2016
Comparative Analysis by Early Stage Development, H1 2016
Products under Development by Companies, H1 2016
Products under Investigation by Universities/Institutes, H1 2016
Bone Marrow Transplantation - Pipeline by Anchor Therapeutics, Inc., H1 2016
Bone Marrow Transplantation - Pipeline by Boryung Pharmaceutical Co., Ltd., H1 2016
Bone Marrow Transplantation - Pipeline by Cleveland BioLabs, Inc., H1 2016
Bone Marrow Transplantation - Pipeline by Compugen Ltd., H1 2016
Bone Marrow Transplantation - Pipeline by Mesoblast Limited, H1 2016
Bone Marrow Transplantation - Pipeline by Pluristem Therapeutics Inc., H1 2016
Bone Marrow Transplantation - Pipeline by Taiga Biotechnologies, Inc., H1 2016
Bone Marrow Transplantation - Pipeline by Targazyme, Inc., H1 2016
Assessment by Monotherapy Products, H1 2016
Assessment by Combination Products, H1 2016
Number of Products by Stage and Target, H1 2016
Number of Products by Stage and Mechanism of Action, H1 2016
Number of Products by Stage and Route of Administration, H1 2016
Number of Products by Stage and Molecule Type, H1 2016
Bone Marrow Transplantation Therapeutics - Recent Pipeline Updates, H1 2016
Bone Marrow Transplantation - Dormant Projects, H1 2016
Bone Marrow Transplantation - Discontinued Products, H1 2016
List of Figures
Number of Products under Development for Bone Marrow Transplantation, H1 2016
Number of Products under Development for Bone Marrow Transplantation - Comparative Analysis, H1 2016
Number of Products under Development by Companies, H1 2016
Comparative Analysis by Clinical Stage Development, H1 2016
Comparative Analysis by Early Stage Products, H1 2016
Assessment by Monotherapy Products, H1 2016
Number of Products by Targets, H1 2016
Number of Products by Stage and Targets, H1 2016
Number of Products by Mechanism of Actions, H1 2016
Number of Products by Stage and Mechanism of Actions, H1 2016
Number of Products by Routes of Administration, H1 2016
Number of Products by Stage and Routes of Administration, H1 2016
Number of Products by Molecule Types, H1 2016
Number of Products by Stage and Molecule Types, H1 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report